Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP, Wolmark N; National Surgical Adjuvant Breast and Bowel Project. Krag DN, et al. Among authors: julian tb. Lancet Oncol. 2007 Oct;8(10):881-8. doi: 10.1016/S1470-2045(07)70278-4. Lancet Oncol. 2007. PMID: 17851130 Clinical Trial.
Breast cancer and the NSABP-B32 sentinel node trial.
Krag D, Harlow S, Julian T. Krag D, et al. Breast Cancer. 2004;11(3):221-4; discussion 264-6. doi: 10.1007/BF02984541. Breast Cancer. 2004. PMID: 15550839 Review. No abstract available.
Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer.
Harlow SP, Krag DN, Julian TB, Ashikaga T, Weaver DL, Feldman SA, Klimberg VS, Kusminsky R, Moffat FL Jr, Noyes RD, Beitsch PD. Harlow SP, et al. Among authors: julian tb. Ann Surg. 2005 Jan;241(1):48-54. doi: 10.1097/01.sla.0000149429.39656.94. Ann Surg. 2005. PMID: 15621990 Free PMC article. Clinical Trial.
Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.
Krag DN, Ashikaga T, Harlow SP, Skelly JM, Julian TB, Brown AM, Weaver DL, Wolmark N; National Surgical Adjuvant Breast and Bowel Project. Krag DN, et al. Among authors: julian tb. J Natl Cancer Inst. 2009 Oct 7;101(19):1356-62. doi: 10.1093/jnci/djp281. Epub 2009 Aug 24. J Natl Cancer Inst. 2009. PMID: 19704072 Free PMC article. Clinical Trial.
Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N; National Surgical Adjuvant Breast, Bowel Project. Ashikaga T, et al. Among authors: julian tb. J Surg Oncol. 2010 Aug 1;102(2):111-8. doi: 10.1002/jso.21535. J Surg Oncol. 2010. PMID: 20648579 Free PMC article. Clinical Trial.
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.
Land SR, Kopec JA, Julian TB, Brown AM, Anderson SJ, Krag DN, Christian NJ, Costantino JP, Wolmark N, Ganz PA. Land SR, et al. Among authors: julian tb. J Clin Oncol. 2010 Sep 1;28(25):3929-36. doi: 10.1200/JCO.2010.28.2491. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679600 Free PMC article. Clinical Trial.
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Wolmark N. Krag DN, et al. Among authors: julian tb. Lancet Oncol. 2010 Oct;11(10):927-33. doi: 10.1016/S1470-2045(10)70207-2. Lancet Oncol. 2010. PMID: 20863759 Free PMC article. Clinical Trial.
Effect of occult metastases on survival in node-negative breast cancer.
Weaver DL, Ashikaga T, Krag DN, Skelly JM, Anderson SJ, Harlow SP, Julian TB, Mamounas EP, Wolmark N. Weaver DL, et al. Among authors: julian tb. N Engl J Med. 2011 Feb 3;364(5):412-21. doi: 10.1056/NEJMoa1008108. Epub 2011 Jan 19. N Engl J Med. 2011. PMID: 21247310 Free PMC article. Clinical Trial.
135 results